Journal Mobile Options
Table of Contents
Vol. 32, No. 3, 2002
Issue release date: May–June 2002 (October 2002)
Section title: Original Paper
Pathophysiol Haemost Thromb 2002;32:131–133

Prospective Assessment of a Nomogram for the Initiation of Oral Anticoagulation Therapy for Outpatient Treatment of Venous Thromboembolism

Kovacs M.J.a · Anderson D.A.b · Wells P.S.c
aDepartments of Medicine,aLondon Health Sciences Centre, London, Ontario, bQueen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, cOttawa Civic Hospital, Ottawa, Ontario, Canada
email Corresponding Author

Dr. Michael J. Kovacs

Room 2760, Phase 1, London Health Sciences Centre

800 Commissioners Road East

London, Ontario N6A 4G5 (Canada)

Tel. +1 519 685 8475, Fax +1 519 685 8477, E-Mail


  1. Weinmann EE, Salzman EW: Deep-vein thrombosis. N Engl J Med 1994;331:1630–1641.
  2. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S, Willan A: A comparison of low-molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:667–681.
  3. Brandjes DP, Heijboer H, Buller HR, de Rijk M, Jagt TH, ten Cate JW: Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992;327:1485–1489.
  4. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH: Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The TASMAN Study Group. N Engl J Med 1996;334:682–687.
  5. Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J: Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. Arch Intern Med 1998;158:1809–1812.
  6. Kovacs MJ, Cruickshank M, Wells PS, Kim H, Chin-Yee I, Morrow B, Boyle E, Kovacs J: Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 1998;28:62–69.
  7. Fennerty A, Bolben J, Thomas P, Backhouse G, Bentley DP, Campbell IA, Routledge PA: Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J Clin (Res Ed) 1984;288:1268–1270.
  8. Doecke CJ, Cosh DG, Gallus AS: Standardized initial warfarin treatment: Evaluation of initial treatment response and maintenance dose prediction by randomized trial, and risk factors for an excessive warfarin response. Aust NZ J Med 1991;21:319–324.
  9. Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirst J: Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 1997;126:133–136.
  10. Crowther MA, Harrison L, Hirsh J: Warfarin: Less may be better. Ann Intern Med 1997;127:332–333.